Related Experiment Video

Updated: May 6, 2026

Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library
08:40

Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library

Published on: April 6, 2012

18.5K

MiR-101 functions as a tumor suppressor by directly targeting nemo-like kinase in liver cancer

Qingyu Shen1, Hyun Jin Bae1, Jung Woo Eun1

  • 1Lab of Oncogenomics, Department of Pathology, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea; Functional RNomics Research Center, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.

Cancer Letters
|November 6, 2013
PubMed

Insights

MicroRNA-101 (miR-101) suppresses hepatocellular carcinoma (HCC) by targeting Nemo-like kinase (NLK). Restoring miR-101 inhibits liver cancer growth and proliferation, highlighting its tumor-suppressive role.

Area of Science:

  • Molecular Biology
  • Oncology
  • Genetics

Background:

  • Nemo-like kinase (NLK), a MAP kinase-related kinase, is implicated in hepatocellular carcinoma (HCC) development.
  • The precise mechanisms driving oncogenic NLK activity in liver cancer remain unclear.

Purpose of the Study:

  • To investigate the role of microRNAs (miRNAs) in regulating NLK expression in HCC.
  • To identify specific miRNAs that target and suppress NLK in liver cancer cells.

Main Methods:

  • Comprehensive miRNA profiling of human HCC tissues.
  • Ectopic expression of miRNA mimics in HCC cell lines.
  • Assessment of NLK expression, cancer cell growth, and proliferation following miRNA manipulation.

Main Results:

  • Four downregulated miRNAs were identified in HCC tissues, with miR-101 showing potential to target NLK.
  • Ectopic miR-101 expression significantly suppressed NLK levels in HCC cells.
  • Restored miR-101 inhibited HCC cell growth and proliferation, mimicking NLK knockdown effects.

Conclusions:

  • miR-101 functions as a tumor suppressor in hepatocellular carcinoma.
  • The tumor-suppressive activity of miR-101 is mediated through the regulation of abnormal NLK activity.
  • Targeting miR-101 may offer a therapeutic strategy for liver cancer.
Keywords:
Liver cancerMiR-101NLKTumor suppressor

More Related Videos

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells09:45

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells

Published on: May 21, 2019

8.1K
In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice07:02

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

Published on: August 23, 2019

7.1K

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.1K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.2K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
5.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
7.6K